Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss.
Growth stimulation by oestrogens in immunodeficient mice is characteristically restricted to tumours expressing oestrogen receptors (ER). We now describe oestrogen-stimulated growth of the ER-negative human breast cancer cell line MDA-MB-231, subclone 10A. Cell culture experiments confirmed that 10A cells are unresponsive to a wide concentration range of oestradiol (E2) in vitro. Analysis of growth curves in vivo revealed significantly longer tumour volume doubling times for the control group than for the E2-treated group. Cell cycle studies using in vivo labelling with bromodeoxyuridine (BrdU) and flow cytometric analysis showed essentially equal potential doubling times for controls and E2-treated animals. These results suggest that E2 reduces cell loss, rather than stimulating proliferation. E2-stimulated growth was seen in both natural killer (NK) cell producing athymic (nude) mice and congenitally NK cell deficient beige nude mice. We conclude that E2-induced natural killer cell suppression is an unlikely mechanism of action.
Robert H. Lurie Cancer Center, Northwestern University Medical School, Chicago, Illinois 60611-3008.
A
A
Friedl
V C
VC
Jordan
D000818:Animals; D001943:Breast Neoplasms / Q000737:chemistry / Q000276:immunology / Q000473:pathology*; D002453:Cell Cycle / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007694:Killer Cells, Natural / Q000276:immunology; D007700:Kinetics; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D011960:Receptors, Estrogen / Q000032:analysis*; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured / Q000187:drug effects
D011960:Receptors, Estrogen; D004958:Estradiol